Protective Efficacy of a Novel DNA Vaccine with a CL264 Molecular Adjuvant against Toxoplasma gondii in a Murine Model

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Vaccines

Topics

Biology

Epidemiology

Immunology

Parasitology

Splenocyte

Show all topics

DOI

10.3390/vaccines12060577

License

CC-BY

Other Formats

PDF